Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data - Uganda, 2012-2015.

Scott C, Walusimbi S, Kirenga B, Joloba M, Winters M, Abdunoor N, Bain R, Alexander H, Shinnick T, Toney S, Odeke R, Mwangi C, Birabwa E, Dejene S, Mugabe F, YaDiul M, Cavanaugh JS.

MMWR Morb Mortal Wkly Rep. 2017 Mar 31;66(12):339-342. doi: 10.15585/mmwr.mm6612a6.

2.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.

3.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):e1-e33. doi: 10.1093/cid/ciw694. Epub 2016 Dec 8.

PMID:
27932390
4.

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs.

Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M.

Geneva: World Health Organization; 2008.

5.

Experience in implementing a quality management system in a tuberculosis laboratory, Kisumu, Kenya.

Musau S, McCarthy K, Okumu A, Shinnick T, Wandiga S, Williamson J, Cain K.

Int J Tuberc Lung Dis. 2015 Jun;19(6):693-5. doi: 10.5588/ijtld.14.0886.

PMID:
25946361
6.

Defining the needs for next generation assays for tuberculosis.

Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, Gilpin C, Boehme CC, Schito M, Kimerling M, Pai M.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S29-38. doi: 10.1093/infdis/jiu821. Review.

7.

Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.

Baldwin PR, Reeves AZ, Powell KR, Napier RJ, Swimm AI, Sun A, Giesler K, Bommarius B, Shinnick TM, Snyder JP, Liotta DC, Kalman D.

Eur J Med Chem. 2015 Mar 6;92:693-9. doi: 10.1016/j.ejmech.2015.01.020. Epub 2015 Jan 10.

8.

Evaluation of the Cepheid Xpert MTB/RIF assay.

Shinnick TM, Starks AM, Alexander HL, Castro KG.

Expert Rev Mol Diagn. 2015 Jan;15(1):9-22. doi: 10.1586/14737159.2015.976556. Epub 2014 Nov 6. Review.

9.

GeneXpert for TB diagnosis: planned and purposeful implementation.

Piatek AS, Van Cleeff M, Alexander H, Coggin WL, Rehr M, Van Kampen S, Shinnick TM, Mukadi Y.

Glob Health Sci Pract. 2013 Mar 21;1(1):18-23. doi: 10.9745/GHSP-D-12-00004. eCollection 2013 Mar. Review.

10.

Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.

Reeves AZ, Campbell PJ, Sultana R, Malik S, Murray M, Plikaytis BB, Shinnick TM, Posey JE.

Antimicrob Agents Chemother. 2013 Apr;57(4):1857-65. doi: 10.1128/AAC.02191-12. Epub 2013 Feb 4.

11.

Global laboratory initiative tool for a stepwise process towards tuberculosis laboratory accreditation.

Datema TA, Oskam L, Engelberts MF, van Beers SM, Shinnick TM, Baker M, Ridderhof JC, Scholten J, van Deun A, Gilpin C, Klatser PR.

Int J Tuberc Lung Dis. 2012 May;16(5):704-5. doi: 10.5588/ijtld.11.0701. No abstract available.

PMID:
22507938
12.

Back to the future: host-targeted chemotherapeutics for drug-resistant TB.

Napier RJ, Shinnick TM, Kalman D.

Future Microbiol. 2012 Apr;7(4):431-5. doi: 10.2217/fmb.12.19. No abstract available.

PMID:
22439718
13.

Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis.

Napier RJ, Rafi W, Cheruvu M, Powell KR, Zaunbrecher MA, Bornmann W, Salgame P, Shinnick TM, Kalman D.

Cell Host Microbe. 2011 Nov 17;10(5):475-85. doi: 10.1016/j.chom.2011.09.010. Erratum in: Cell Host Microbe. 2011 Dec 15;10(6):635.

14.

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.

Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, Kellar KL, Posey JE, Plikaytis BB, Amara RR, Shinnick TM.

PLoS One. 2011;6(7):e22718. doi: 10.1371/journal.pone.0022718. Epub 2011 Jul 25.

15.

Core gene set as the basis of multilocus sequence analysis of the subclass Actinobacteridae.

Adékambi T, Butler RW, Hanrahan F, Delcher AL, Drancourt M, Shinnick TM.

PLoS One. 2011 Mar 31;6(3):e14792. doi: 10.1371/journal.pone.0014792.

16.

Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin.

Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, Lafuse WP, Shinnick TM, Sable SB.

Tuberculosis (Edinb). 2011 Jul;91(4):314-21. doi: 10.1016/j.tube.2011.03.003. Epub 2011 Apr 8.

PMID:
21482189
17.

Building tuberculosis laboratory capacity: Needs and strategies.

Shinnick TM.

Rev Port Pneumol. 2010 Jan;16SA:S57-65. doi: 10.1016/S0873-2159(15)30094-5. English, Portuguese. No abstract available.

18.

Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.

Zaunbrecher MA, Sikes RD Jr, Metchock B, Shinnick TM, Posey JE.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20004-9. doi: 10.1073/pnas.0907925106. Epub 2009 Nov 11.

19.

Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Starks AM, Gumusboga A, Plikaytis BB, Shinnick TM, Posey JE.

Antimicrob Agents Chemother. 2009 Mar;53(3):1061-6. doi: 10.1128/AAC.01357-08. Epub 2008 Dec 22.

20.

Complete rpoB gene sequencing as a suitable supplement to DNA-DNA hybridization for bacterial species and genus delineation.

Adékambi T, Shinnick TM, Raoult D, Drancourt M.

Int J Syst Evol Microbiol. 2008 Aug;58(Pt 8):1807-14. doi: 10.1099/ijs.0.65440-0.

PMID:
18676461
21.

Genome-wide analysis of intergenic regions of Mycobacterium tuberculosis H37Rv using Affymetrix GeneChips.

Fu LM, Shinnick TM.

EURASIP J Bioinform Syst Biol. 2007:23054. doi: 10.1155/2007/23054.

22.

Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia.

Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM.

Clin Microbiol Infect. 2007 Jun;13(6):620-6. Epub 2007 Apr 2.

23.

Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.

Sable SB, Plikaytis BB, Shinnick TM.

Vaccine. 2007 Feb 19;25(9):1553-66. Epub 2006 Nov 15. Review.

PMID:
17166640
24.

The acid-induced operon Rv3083-Rv3089 is required for growth of Mycobacterium tuberculosis in macrophages.

Cheruvu M, Plikaytis BB, Shinnick TM.

Tuberculosis (Edinb). 2007 Jan;87(1):12-20. Epub 2006 Aug 8.

PMID:
16893682
25.

Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips.

Fu LM, Shinnick TM.

Tuberculosis (Edinb). 2007 Jan;87(1):63-70. Epub 2006 Aug 2.

PMID:
16890025
26.

Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis.

Caoili JC, Mayorova A, Sikes D, Hickman L, Plikaytis BB, Shinnick TM.

J Clin Microbiol. 2006 Jul;44(7):2378-81.

27.
28.

Tuberculosis: integrating host and pathogen biology. A summary of the 2005 Keystone Symposia.

Fallows D, Murray RA, Kaplan G, Shinnick T.

Tuberculosis (Edinb). 2006 Mar;86(2):144-8. No abstract available.

PMID:
16557661
29.

Public health. A National Tuberculosis Archive.

Gessler D, Dye C, Farmer P, Murray M, Navin T, Reves R, Shinnick T, Small PM, Yates T, Simpson G.

Science. 2006 Mar 3;311(5765):1245-6. No abstract available.

PMID:
16513968
30.

Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis.

Posey JE, Shinnick TM, Quinn FD.

J Bacteriol. 2006 Feb;188(4):1332-40.

31.

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.

Maus CE, Plikaytis BB, Shinnick TM.

Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7.

33.

Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.

Maus CE, Plikaytis BB, Shinnick TM.

Antimicrob Agents Chemother. 2005 Feb;49(2):571-7.

34.

Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates.

Shemyakin IG, Stepanshina VN, Ivanov IY, Lipin MY, Anisimova VA, Onasenko AG, Korobova OV, Shinnick TM.

Int J Tuberc Lung Dis. 2004 Oct;8(10):1194-203.

PMID:
15527151
35.

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.

Stanford M, Whittall T, Bergmeier LA, Lindblad M, Lundin S, Shinnick T, Mizushima Y, Holmgren J, Lehner T.

Clin Exp Immunol. 2004 Jul;137(1):201-8.

36.

Immunopathogenesis and prevention of uveitis with the Behçet's disease-specific peptide linked to cholera toxin B.

Lehner T, Stanford MR, Phipps PA, Sun JB, Xiao BG, Holmgren J, Shinnick T, Hasan A, Mizushima Y.

Adv Exp Med Biol. 2003;528:173-80. Review. No abstract available.

PMID:
12918685
37.

Resuscitation factors from mycobacteria: homologs of Micrococcus luteus proteins.

Zhu W, Plikaytis BB, Shinnick TM.

Tuberculosis (Edinb). 2003;83(4):261-9.

PMID:
12906837
38.

I-TRAP: a method to identify transcriptional regulator activated promoters.

McLendon MM, Shinnick TM.

BMC Infect Dis. 2003 Jul 11;3:15.

39.

Transformation of Rhodococcus rhodnii, a symbiont of the Chagas disease vector Rhodnius prolixus, with integrative elements of the L1 mycobacteriophage.

Dotson EM, Plikaytis B, Shinnick TM, Durvasula RV, Beard CB.

Infect Genet Evol. 2003 Jul;3(2):103-9.

PMID:
12809804
40.

Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit.

Phipps PA, Stanford MR, Sun JB, Xiao BG, Holmgren J, Shinnick T, Hasan A, Mizushima Y, Lehner T.

Eur J Immunol. 2003 Jan;33(1):224-32.

41.

A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures.

Jasmer RM, Roemer M, Hamilton J, Bunter J, Braden CR, Shinnick TM, Desmond EP.

Emerg Infect Dis. 2002 Nov;8(11):1260-3.

42.
43.
44.

Defining a T-cell epitope within HSP 65 in recurrent aphthous stomatitis.

Hasan A, Shinnick T, Mizushima Y, van der Zee R, Lehner T.

Clin Exp Immunol. 2002 May;128(2):318-25.

45.
46.

Diagnostic test needs for evaluating antituberculosis vaccines.

Shinnick TM.

Clin Infect Dis. 2000 Jun;30 Suppl 3:S276-8. Review.

PMID:
10875799
47.

T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease.

Direskeneli H, Ekşioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, Akoglu T.

J Rheumatol. 2000 Mar;27(3):708-13.

PMID:
10743813
48.

Multiplex PCR assay to aid in the identification of the highly transmissible Mycobacterium tuberculosis strain CDC1551.

Plikaytis BB, Kurepina N, Woodley CL, Fleischmann R, Kreiswirth B, Shinnick TM.

Tuber Lung Dis. 1999;79(5):273-8.

PMID:
10707255
49.

Supplemental Content

Loading ...
Support Center